22nd CIMT
Annual Meeting


May 12-14, 2025
Rheingoldhalle Congress Center Mainz, Germany

Europe's Cancer Immunotherapy Meeting

Speakers & Program

CIMT News

December 21, 2021
This is some text inside of a div block.

CIMT Annual Meeting 2022 program to again showcase hottest topics in cancer immunotherapy

From cutting-edge basic research to the latest translational applications, the 2022 CIMT Annual Meeting will again cover the latest advances in the field. Stay tuned for more information to be posted in January.

Read more
April 4, 2025
2025-04-04 13:12

2025 abstract notifications

All abstracts have been reviewed. Abstract notifications will be sent on April 7.

March 20, 2025
2025-03-20 12:25

Rolf Kiessling receives CIMT Lifetime Achievement Award

The Swedish researcher Rolf Kiessling is the recipient of the 2025 CIMT Lifetime Achievment Award. The award will be presented at the CIMT Annual Meeting on the evening of Tuesday, May 13, at 6 p.m.

March 7, 2025
2025-03-07 17:55

Extended abstract submission deadline

Due to high activity on our abstract submission platform, we have extended the CIMT Annual Meeting abstract deadline!  

New submission deadline: March 14 (midnight CET)

February 27, 2025
2025-02-27 14:54

Submit your abstract before the deadline

Submit your abstract by March 7 and take part in the 22nd CIMT Annual Meeting program. To submit, go to ww.meeting.cimt.eu/call-for-abstracts .

January 6, 2025
2025-01-06 12:21

Registration and abstract submission now open

We are excited to announce that registration and abstract submission for the 22nd CIMT Annual Meeting are now open! Submit your abstract and present your research in Mainz, Germany, May 12-14, 2025.

July 24, 2024
2024-07-24 15:38

21st CIMT Annual Meeting report

The meeting report of the 21st CIMT Annual Meeting has been published in Human Vaccines & Immunotherapeutics. DOI: 10.1080/21645515.2024.2381925

May 15, 2024
2024-05-15 11:11

The 21st CIMT Annual Meeting kicks off in Mainz, Germany

The 21st Annual Meeting of the Association for Cancer Immunotherapy (CIMT) has officially opened today in Mainz, Germany, drawing 870 participants from 32 countries.

May 14, 2024
2024-05-14 14:29

Abstracts of the 21st CIMT Annual Meeting

View the abstracts of the 21st CIMT Annunal Meeting at www.meeting.cimt.eu/speakers-and-program.

April 11, 2024
2024-04-11 12:42

Abstract presentation notifications have been sent.

If you have submitted an abstract, please check your email inbox, including your spam folder.

All conference abstracts will be published on this webseite and on the conference app on May 13.

March 8, 2024
2024-03-08 19:03

Abstract submission extended through March 15

The abstract submission for the 21st CIMT Annual Meeting has been extended through March 15 (CET).

2025 Plenary Speakers

Cornelis J.M. Melief
Leiden University Medical Center & ISAbella Pharma
The Netherlands
Karina Silina
ETH Zurich
Switzerland
Maria Sibilia
Center for Cancer Research, Medical University of Vienna
Austria
Guangyuan Li
New York University
USA
Manuel Valiente
Molecular Oncology Programme, CNIO
Spain
Nikolaos G. Sgourakis
University of Pennsylvania & Children's Hospital of Philadelphia
USA
Karen Dixon
University of Basel
Switzerland
Lukas Bunse
German Cancer Research Center DKFZ
David Gfeller
Ludwig Institute for Cancer Research Lausanne
Switzerland
Ilaria Elia
KU Leuven
Belgium
Susana Minguet
University of Freiburg
Germany
Dario Neri
Philogen/ETH Zurich
Switzerland
Stanley Qi
Stanford University
USA
Ronald Germain
National Institute of Allergy and Infectious Diseases National Institutes of Health
USA
Barbara Maier
CeMM Vienna
Austria
Matthew Spitzer
UC San Francisco
USA
Marit van Buuren
BioNTech
USA
Sine Reker Hadrup
Technical University of Denmark
Denmark
Hideho Okada
UC San Francisco
USA
All Speakers

Join the CIMT Experience

Every year, the CIMT Annual Meeting connects the global cancer immunotherapy community in the heart of Europe. As the largest meeting focused on cancer immunotherapy research and development in Europe, CIMT invites international participants for high-level scientific exchange, collaboration, and education focused on cancer immunotherapy.

Subscribe to the CIMT newsletter

Stay up to date on Europe’s largest meeting focused on cancer immunotherapy research and development

Our 2025 Sponsors

Educational Funding

Our 2025 Media Partnerships

Our 2025 Industry Exhibitors